Phosphate-induced vascular calcification: Role of pyrophosphate and osteopontin

Journal of the American Society of Nephrology

Volumn 15, Issue 6, 2004, Pages 1392-1401

  Lomashvili, Koba A ^a   Cobbs, Scott ^a   Hennigar, Randolph A ^a   Hardcastle, Kenneth I ^b   O'Neill, W Charles ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; HYDROXYAPATITE; INORGANIC PYROPHOSPHATASE; OSTEOPONTIN; PHOSPHATE; PYROPHOSPHATE;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL CALCIFICATION; BLOOD VESSEL INJURY; CALCIFICATION; CONTROLLED STUDY; CULTURE MEDIUM; DEPHOSPHORYLATION; HISTOLOGY; HYDROLYSIS; HYPERPHOSPHATEMIA; IN VITRO STUDY; KIDNEY FAILURE; MECHANICAL TRAUMA; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR; TISSUE CULTURE; VASCULAR RING; X RAY DIFFRACTION;

EID: 2542471518     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000128955.83129.9C     Document Type: Article

References (46)

1. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000
2. Shanahan CM, Cary NRB, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME: Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: Evidence for smooth muscle cell-mediated vascular calcification. Circulation 100: 2168-2176, 1999
3. Jeziorska M, McCollum C, Woolley DE: Calcification in atherosclerotic plaque of human carotid arteries: Associations with mast cells and macrophages. J Pathol 185: 10-17, 1998
4. Ibels LS, Alfrey AC, Huffer WE, Craswell PW, Anderson JT, Weil R: Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 66: 790-796, 1979
5. Ejerblad S, Ericsson JLE, Erikson I: Arterial lesions of the radial artery in uraemic patients. Acta Chir Scand 145: 415-428, 1979
6. Everhart JE, Pettitt DJ, Knowler WC, Rose FA, Bennett PH: Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia 31: 16-23, 1988
7. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature 386: 78-81, 1997
8. Price PA, Faus SA, Williamson MK: Warfarin causes rapid calcification of the elastic lamella in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 18: 1400-1407, 1998
9. Ahmed S, O'Neill KD, Hood AF, Evan AP, Moe SM: Calciphylaxis Is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 37: 1267-1276, 2001
10. Denhardt DT, Guo X: Osteopontin: A protein with diverse functions. FASEB J 7: 1475-1482, 1993
11. Wada T, McKee MD, Steitz S, Giachelli CM: Calcification of vascular smooth muscle cell cultures. Inhibition by osteopontin. Circ Res 84: 166-178, 1999
12. Jono S, Peinado C, Giachelli CM: Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 275: 20197-20203, 2000
13. Speer MY, McKee MD, Guldberg RE, Liaw L, Yang H-Y, Tung E, Karsenty G, Giachelli CM: Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196: 1047-1055, 2002
14. Min H, Morony S, Sarosi I, Dunstan CR, Caparelli C, Scully S, Van G, Kaufman S, Kostenuik PJ, Lacey DL, Boyle WJ, Simonet WS: Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 192: 463-474, 2000
15. Bucay N, Sarosi I, Dunstan C, Moroney S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12: 1260-1268, 1998
16. Jahnen-Dechent W, Schinke T, Trindl A, Muller-Esterl W, Sablitzky F, Kaiser S, Blessing M: Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272: 31496-31503, 1997
17. 2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. J Biol Chem 271: 20789-20796, 1996
18. Jiang G, Cobbs S, Klein JD, O'Neill WC: Aldosterone regulates the Na-K-2Cl cotransporter in vascular smooth muscle. Hypertension 41: 1131-1135, 2003
19. Fingerle J, Au YP, Clowes AW, Reidy MA: Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 10: 1082-1087, 1990
20. Zeidan A, Nordstrom I, Dreja K, Malmqvist U, Hellstrand P: Stretch-dependent modulation of contractility and growth in smooth muscle of rat portal vein. Circ Res 87: 228-234, 2000
21. Aurbach GD, Marx SJ, Spiegel AM: Parathyroid hormone, calcitonin, and the calciferols. In: Williams Textbook of Endocrinology, 7th Ed., edited by Wilson JD, Foster DW, Philadelphia, W.B. Saunders, 1985, pp 1137-1217
22. Cheung CP, Suhadolnik RJ: Analysis of inorganic pyrophosphate at the picomole level. Anal Biochem 83: 61-63, 1977
23. Grobben B, Anciaux K, Roymans D, Stefan C, Bollen M, Esmans EL, Slegers H: An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 Glioma. J Neurochem 72: 826-834, 1999
24. Loo DT, Rillema JR: Measurement of cell death. Methods Cell Biol 57: 251-264, 1998
25. Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H: b-Glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 15: 2003-2009, 1995
26. Meyer JL: Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys 231: 1-8, 1984
27. Sakata N, Noma A, Yamamoto Y, Okamoto K, Meng J, Takebayashi S, Nagai R, Horiuchi S: Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease. Nephrol Dial Transplant 18: 1601-1609, 2003
28. Katsura K, Kusek JW, Hirata Y, Tsunemi K, Nagano N, Burke SK, Fukushima N: Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int 64: 441-450, 2003
29. Fleisch H, Neuman WF: Mechanism of calcification: role of collagen, polyphosphates, and phosphatase. Am J Physiol 200: 1296-1300, 1961
30. Fleisch H, Russell GG, Straumann F: Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212: 901-903, 1966
31. Fleisch H, Schibler D, Maerki J, Frossard I: Inhibition of aortic calcification by means of pyrophosphate and polyphosphates. Nature 207: 1300-1301, 1965
32. 3 in rats. Clin Sci 35: 363-372, 1968
33. Russell RGG, Bisaz S, Fleisch H: Pyrophosphate and diphosphates in calcium metabolism and their possible role in renal failure. Arch Intern Med 124: 571-575, 1969
34. Francis MD, Russell RGG, Fleisch H: Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathologic calcification in vivo. Science 165: 1264-1266, 1969
35. Russell RGG, Bisaz S, Donath A, Morgan DB, Fleisch H: Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone. J Clin Invest 50: 961-969, 1971
36. Rachow JW, Ryan LM: Inorganic pyrophosphate metabolism in arthritis. Rheum Dis Clin North Am 14: 289-302, 1988
37. Whyte MP: Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15: 439-461, 1994
38. Fleisch H, Bisaz S: Mechanism of calcification: inhibitory role of pyrophosphate. Nature 195: 911, 1962
39. Rutsch F, Vaingankar S, Johnson K, Goldfine I, Maddux B, Schauerte P, Kalhoff H, Sano K, Boisvert WA, Superti-Furga A, Terkeltaub RA: PC-1 nucleotide triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 158: 543-554, 2001
40. Ho AM, Johnson MD, Kingsley DM: Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289: 265-270, 2000
41. Schwarz G, Stork H: The role of pyrophosphate and alkaline phosphatase in skin calcification (calciphylaxis). Experientia 23: 295-296, 1967
42. Mazhar AR, Johnson RJ, Gillen D, Stivelman JC, Ryan MJ, Davis CL, Stehman-Breen C: Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 60: 324-332, 2001
43. Gadeau A-P, Chaulet H, Daret D, Kockx M, Daniel-Lamaziere J-M, Desgranges C: Time course of osteopontin, osteocalcin, and osteonectin accumulation and calcification after acute vessel wall injury. J Histochem Cytochem 49: 79-86, 2001
44. Hao H, Hirota S, Tsukamoto Y, Imakita M, Ishibashi-Ueda H, Yutani C: Alterations of bone matrix protein mRNA expression in rat aorta in vitro. Arterioscler Thromb Vasc Biol 15: 1474-1480, 1995
45. Liaw L, Birk DE, Ballas CB, Aagenaes O, Whitsitt JS, Davidson JM, Hogan BLM: Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 101: 1468-1478, 1998
46. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT: Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13: 1101-1111, 1998